Download MendeleyDesign and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl DPP-IV inhibitors.
Corbett, J.W., Dirico, K., Song, W., Boscoe, B.P., Doran, S.D., Boyer, D., Qiu, X., Ammirati, M., Vanvolkenburg, M.A., McPherson, R.K., Parker, J.C., Cox, E.D.(2007) Bioorg Med Chem Lett 17: 6707-6713
- PubMed: 17977724
- DOI: https://doi.org/10.1016/j.bmcl.2007.10.063
- Primary Citation of Related Structures:
2RIP - PubMed Abstract:
The cis-3-amino-4-(2-cyanopyrrolidide)-pyrrolidine template has been shown to afford low nanomolar inhibitors of human DPP-IV that exhibit a robust PK/PD profile. An X-ray co-crystal structure of 5 confirmed the proposed mode of binding. The potent single digit DPP-IV inhibitor 53 exhibited a preferred PK/PD profile in preclinical animal models and was selected for additional profiling.
Organizational Affiliation:
Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, USA.
